Identification of an association between HLA class II alleles and low antibody levels after measles immunization

Vaccine

Volumn 20, Issue 3-4, 2001, Pages 430-438

  Poland, Gregory A ^a   Ovsyannikova, Inna G ^a   Jacobson, Robert M ^a,b   Vierkant, Robert A ^b   Jacobsen, Steven J ^b   Pankratz, V Shane ^b   Schaid, Daniel J ^b  

^a Mayo Vaccine Research Group   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Antibody response; HLA; Measles

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HUMORAL ANTIBODY; MEASLES MUMPS RUBELLA VACCINE;

ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN EXPERIMENT; IMMUNOGENETICS; MALE; MEASLES; MEASLES VACCINATION; NORMAL HUMAN; PRIORITY JOURNAL; SEROPREVALENCE; WORLD HEALTH ORGANIZATION;

ALLELES; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; GENES, MHC CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNIZATION; INFANT; MALE; MEASLES VACCINE;

EID: 0035851330     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00346-2     Document Type: Article

References (61)

1. The epidemiology of measles: 30 years of vaccination
2. Measles virus
3. Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons
4. Measles vaccine
5. Secondary failure rates of measles vaccines: A meta-analysis of published studies
6. Immunity against measles and rubella in Massachusetts school children
7. Antibody response following measles-mumps-rubella vaccine under conditions of customary use
8. Measles re-immunization in children seronegative after initial immunizaton
9. The association between measles vaccine and mumps vaccine failure in a cohort of the US school children
10. The genetic basis for variation in antibody response to vaccines
11. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination
12. Variability in immune response to pathogens: Using measles vaccine to probe immunogenetic determinants of response
13. Association of HLA-DQB1 alleles and antibody levels after measles immunization: Preliminary results
14. Immunogenetic mechanisms of antibody response to measles vaccine: The role of the HLA genes
15. Secondary measles vaccine failures identified by measurement of IgG avidity: High occurrence among teenagers vaccinated at a young age
16. Duration of live measles vaccine-induced immunity
17. Measles antibody: Reevaluation of protective titers
18. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody
19. Development and evaluation of the Moraten measles virus vaccine
20. Modern concepts in immune recognition and lymphocyte activation: Relevance for the development of useful vaccines
21. The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines
22. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
23. Class II MHC molecules can use the endogenous pathway of antigen presentation
24. The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules
25. Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjects
26. Enzyme-linked immunosorbent assay for detection of measles antibody
27. A recovered avian myelocytomatosis virus that induces lymphomas in chickens: Pathogenic properties and their molecular basis
28. HLA-DR typing by PCR amplification with sequence-specific primer (PCR-SSP) in 2 h: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
29. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primer (PCR-SSP) in 2 h
30. A DNA-RFLP typing system which positively identifies serologically well-defined and ill-defined HLA-DR and -DQ alleles, including DRw10
31. HLA-DQB1 low-resolution typing by PCR amplification with sequence-specific primer (PCR-SSP)
32. HLA-DPA1 typing by PCR amplification with sequence-specific primer (PCR-SSP) and distribution of DPA1 alleles in Caucasion, African and Oriental populations
33. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci
34. Performing the exact test of Hardy-Weinberg proportion for multiple alleles
35. The association between measles vaccine-induced antibody response and HLA-DQA1 alleles
36. The influence of the HLA-DRB1*13 allele on measles vaccine response
37. Peptide blinding motifs and specificities for HLA-DQ molecules
38. HLA association with hepatitis C virus infection
39. Presentation of an immunodominant T cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule
40. SB-restricted presentation of influenza and herpes simplex virus antigens to human T lymphocyte clones
41. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP
42. Rubella gene sequencing as a clinician's tool
43. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
44. V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor
45. The immune response to hepatitis B vaccine in humans: Inheritance patterns in families
46. Genetic prediction of non-response to hepatitis B vaccine
47. Naturally processed peptides from two disease-resistance associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRb chain
48. Non-response to a recombinant pre-S2-containing hepatitis B vaccine: Association with the HLA-system
49. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients
50. MHC class II genes influence the susceptibility to chronic active hepatitis C
51. HLA-DQ associations in type 1 autoimmune hepatitis
52. Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam
53. Perspective: Hypothesis. Serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum
54. The paradigms of measles vaccinology
55. Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immuno-fluorescence and plaque neutralization tests
56. Role of virus strain in conventional and enhanced measles plaque neutralization test
57. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus
58. Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses
59. Susceptibility in USAF recruits to vaccine-preventable diseases
60. The risk of measles, mumps, and varicella among young adults: A serosurvey of the US Navy and Marine Corps recruits